Sunesis Pharmaceutic (SNSS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select FieldsSymbol | SNSS | GNTA | LPTX | ||
Company | Sunesis Pharmaceutic | Genenta Science S.P.A. ADR | Leap Therapeutics Inc | ||
Price Information | |||||
Exchange | NASDAQ | NASDAQ | NASDAQ | ||
Open | 16.35 | 5.22 | 3.71 | ||
High | 24.80 | 5.45 | 3.96 | ||
Low | 16.35 | 5.22 | 3.70 | ||
Last | 18.62 | 5.45 | 3.74 | ||
Change | +3.64 | +0.35 | unch | ||
% Change | +24.30% | +6.86% | unch | ||
Volume | 20,069,086 | 6,100 | 211,800 | ||
20-Day Average Volume | 6,608,405 | 28,055 | 435,020 | ||
Previous Close | 14.98 | 5.10 | 3.74 | ||
Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
Has Options | No | No | Yes | ||
Technicals | |||||
20-Day Moving Average | 3.35 | 5.48 | 3.01 | ||
20-Day Raw Stochastic | 62.71% | 35.56% | 59.46% | ||
20-Day Relative Strength | 78.29% | 55.90% | 61.71% | ||
Weighted Alpha | +200.53 | -10.76 | +35.29 | ||
Today's Opinion | 88% Buy | 88% Buy | 88% Buy | ||
Previous Opinion | 88% Buy | 88% Buy | 88% Buy | ||
Last Month's Opinion | 40% Buy | 48% Buy | 24% Sell | ||
Performance | |||||
5-Days | |||||
%Chg | +35.37% since 02/17/21 | +4.32% since 10/25/24 | +3.89% since 10/25/24 | ||
Low | 3.53 on 02/22/21 | 5.02 on 10/31/24 | 3.61 on 10/31/24 | ||
High | 7.09 on 02/24/21 | 5.50 on 10/29/24 | 4.79 on 10/30/24 | ||
1-Month | |||||
%Chg | +75.58% since 01/22/21 | +33.58% since 10/01/24 | +55.19% since 10/01/24 | ||
Low | 2.35 on 01/28/21 | 4.18 on 10/02/24 | 2.20 on 10/15/24 | ||
High | 7.09 on 02/24/21 | 7.28 on 10/10/24 | 4.79 on 10/30/24 | ||
3-Month | |||||
%Chg | +291.18% since 11/24/20 | +23.02% since 08/01/24 | +76.42% since 08/01/24 | ||
Low | 1.33 on 11/25/20 | 3.30 on 09/19/24 | 1.90 on 08/05/24 | ||
High | 7.09 on 02/24/21 | 7.28 on 10/10/24 | 4.79 on 10/30/24 | ||
6-Month | |||||
%Chg | +92.27% since 08/24/20 | +65.91% since 05/01/24 | +14.37% since 05/01/24 | ||
Low | 1.12 on 11/06/20 | 2.79 on 07/08/24 | 1.68 on 07/02/24 | ||
High | 7.09 on 02/24/21 | 7.28 on 10/10/24 | 4.79 on 10/30/24 | ||
Key Statistics | |||||
Market Capitalization, $K | 96,255 | 99,283 | 95,744 | ||
Shares Outstanding, K | 18,093 | 18,217 | 25,600 | ||
Annual Sales | 2,070,000 | 0 | 0 | ||
Annual Net Income | -23,330,000 | -12,600,000 | -81,410,000 | ||
Last Quarter Sales | N/A | N/A | 0 | ||
Last Quarter Net Income | N/A | N/A | -20,130,000 | ||
60-Month Beta | 2.21 | 0.74 | 0.21 | ||
Per-Share Information | |||||
Most Recent Earnings | N/A | N/A | -0.52 on 08/12/24 | ||
Latest Earnings Date | 03/09/21 | 04/24/24 | 11/11/24 | ||
Most Recent Dividend | N/A | N/A | N/A | ||
Next Ex-Dividends Date | N/A | N/A | N/A | ||
Ratios | |||||
Price/Earnings ttm | 0.00 | 0.00 | 0.00 |